Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses

Area of Science:

• Microbiology
• Pharmacology
• Tuberculosis Research

Background:

• Tuberculosis lung lesions contain diverse microenvironments affecting antibiotic efficacy.
• Bacterial phenotypes within these lesions and their role in drug tolerance remain unclear.
• Understanding these factors is crucial for optimizing tuberculosis treatment.

Purpose of the Study:

• To investigate the phenotypic heterogeneity of Mycobacterium tuberculosis within different lung lesion microenvironments.
• To assess how these distinct bacterial populations respond to key anti-tuberculosis drugs.
• To explore the contribution of microenvironmental niches to drug tolerance and prolonged treatment durations.

Main Methods:

• Utilized the C3HeB/FeJ mouse model of tuberculosis.
• Employed the RS ratio, a pharmacodynamic marker measuring rRNA synthesis, to differentiate bacterial phenotypes.
• Analyzed Mycobacterium tuberculosis populations in various tissue microenvironments.

Main Results:

• Demonstrated that Mycobacterium tuberculosis populations in different microenvironments exhibit distinct phenotypes.
• Showed differential responses of these bacterial populations to rifampin, isoniazid, and bedaquiline treatment.
• Established a link between bacterial phenotype, microenvironment, and drug response.

Conclusions:

• Bacterial phenotypes within tuberculosis lung lesions are heterogeneous and influenced by the microenvironment.
• These phenotypic differences significantly impact the effectiveness of antibiotics like rifampin, isoniazid, and bedaquiline.
• The findings provide a basis for understanding drug tolerance and optimizing treatment strategies for human tuberculosis.